Prescription Drug

GlaxoSmithKline’s skin-rash warning for Lamictal is insufficient, a blinded woman claims in <a href="http://www.courthousenews.com/wp-content/uploads/2017/10/Prescription-Drug.pdf"><strong>Clark County Court</strong></a>, saying the drug gave her toxic epidermal necrosis, blistering and peeling more than 80 percent of her skin.

LAS VEGAS — GlaxoSmithKline’s skin-rash warning for Lamictal is insufficient, a blinded woman claims in Clark County Court, saying the drug gave her toxic epidermal necrosis, blistering and peeling more than 80 percent of her skin.

Categories / Health, Personal Injury

Subscribe to our free newsletters

Our weekly newsletter Closing Arguments offers the latest about ongoing trials, major litigation and rulings in courthouses around the U.S. and the world, while the monthly Under the Lights dishes the legal dirt from Hollywood, sports, Big Tech and the arts.